Robotic arm vs. Stereotactic Frame in Deep Brain Stimulation Surgery for Movement Disorders: A Retrospective Cohort Study

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Abstract Background: Recently, robotic arms have been incorporated into electrodes for deep brain stimulation (DBS). Objectives: This study aimed to determine the accuracy of brain electrode placement, initial clinical efficacy, and safety profile of the robotic arm Neuromate (Renishaw) compared to a stereotactic frame in movement disorders. Methods: This study involved two retrospective cohorts: one patient was operated on using a stereotactic frame and the other with a robotic arm. This study was conducted at Barcelona Hospital Clinic. Results: Seventy-seven patients were included, of whom 30 underwent surgery using the robot and 47 using a stereotactic frame. There was a significant improvement in the anatomical-radiological accuracy of brain electrode implantation assisted by the robotic arm, measured using radial error (robot: 1.01 ± 0.5 mm vs. frame: 1.32 ± 0.6 mm, P: 0.03). The postoperative improvement percentage of the Unified Parkinson’s Disease Rating Scale at 3 months was similar in both groups (robot: 71.4 ± 18 vs. frame: 72.6% ± 17, P: 0.82). There were no significant differences in the perioperative complications (robot: 4% vs. frame: 4.3%, P: 0.93) or in the adverse reactions related to brain stimulation and medical treatment (robot: 18% vs. frame: 25%, P: 0.53). Conclusions: The use of the robotic arm Neuromate improved the anatomical-radiological accuracy in the placement of DBS electrodes for movement disorders compared with the stereotactic frame. Both systems (robotic and stereotactic frame) exhibited similar initial clinical efficacies and safety profiles.

Related topics